arrow
Back
P

Petros Grivas

university of washington

61H-index
912Paper Count
2.5WCitation Count
Published Papers 203
Publication Date
Real-world overall survival improvements in metastatic urothelial carcinoma across three key therapeutic temporal periods
err2026-08-24
err0
errOAAI
errA. Cigliola; B.A. Maiorano; G. Guandalini; V. Tateo; C. Mercinelli; M. Piacentini; A. Bertini; N. Dizman; S.K. Pal; S. Gupta; P. Grivas; A. Kamat; P.E. Spiess; N. Agarwal; A. Briganti; F. Montorsi; A. Necchi
errShare
errSave
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
err2026-07-30
err0
PREAI
errSolange Peters; Petros Grivas; Christophe Massard; Sara M. Tolaney; Michel Obeid
errShare
errSave
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus
err2026-06-12
err0
errOAAI
errJ.B. Aragon-Ching; S. Gupta; P. Grivas; S.H. Park; D.P. Petrylak; S.S. Sridhar; H. Gurney; N. Jacob; K. Tyroller; J. Hoffman; J. Bellmunt
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study
err2025-12-01
err0
errOAAI
errJindal, Tanya; Jiang, Cindy Y.; Alhalabi, Omar; Davidsohn, Matthew; Freeman, Dory; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Nizam, Amanda; Nguyen, Charles B.; Oh, Eugene; Tsung, Irene; Glover, Michael J.; Khaki, Ali Raza; Taylor, Amy K.; Jaime-Casas, Salvador; Jang, Albert; Lemke, Emily; Pywell, Cameron; Evans, Sean T.; Shin, Denny; Bilen, Mehmet A.; Basu, Arnab; Kilari, Deepak; Tripathi, Abhishek; Brown, Jason; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Alva, Ajjai; Campbell, Matthew T.; Koshkin, Vadim S.
errShare
errSave
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation
err2025-12-01
err0
PREAI
errRobesti, Daniele; Micheli, Filippo; Rai, Shesh N.; Fallara, Giuseppe; Gallina, Andrea; Montorsi, Francesco; Briganti, Alberto; Fossati, Nicola; Grivas, Petros; van der Heijden, Antoine G.; Ploussard, Guillaume; Malavaud, Bernard; Martini, Alberto
errShare
errSave
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study☆
err2025-11-18
err0
errOAAI
errB.A. Maiorano; A. Cigliola; V. Tateo; C. Mercinelli; G.L. Pastorino; N. Dizman; H. Ebrahimi; S.K. Pal; S. Gupta; P. Grivas; A.M. Kamat; P.E. Spiess; N. Agarwal; A. Necchi
errShare
errSave
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
err2025-11-01
err0
PREAI
errBakaloudi, Dimitra Rafailia; Koehne, Elizabeth L.; Voutsinas, Jenna M.; Diamantopoulos, Leonidas N.; Makrakis, Dimitrios; Grivas, Petros; True, Lawrence D.; Tretiakova, Maria S.; Vakar-Lopez, Funda; Psutka, Sarah P.; Holt, Sarah K.; Gore, John L.; Lin, Daniel W.; Schade, George R.; Nyame, Yaw A.; Hsieh, Andrew C.; Yezefski, Todd; Hawley, Jessica E.; Schweizer, Michael T.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, R. Bruce; Wu, Qian; Wright, Jonathan L.
errShare
errSave
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
err2025-11-01
err0
PREAI
errJiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
errShare
errSave
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract
err2025-11-01
err1
PREAI
errPowles, Thomas; Tagawa, Scott T.; Vulsteke, Christof; Gross-Goupil, Marine; Park, Se Hoon; Necchi, Andrea; De Santis, Maria; Duran, Ignacio; Morales-Barrera, Rafael; Guo, Jun; Sternberg, Cora N.; Bellmunt, Joaquim; Goebell, Peter J.; Kovalenko, Maria; Boateng, Freda; Sierecki, Mitch; Wang, Lu; Sima, Camelia S.; Waldes, Jana; Bangs, Rick; Loriot, Yohann; Grivas, Petros
errShare
errSave
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
err2025-10-02
err0
errOAAI
errNizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
errShare
errSave
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
err2025-09-14
err0
PREAI
errTanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
errShare
errSave
A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy
err2025-09-01
err0
errOAAI
errGrivas, Petros; Tagawa, Gurdeep; Jain, Rohit K.; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P.; Davis, Nancy; Sternberg, Cora N.; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann
errShare
errSave
Early real-world utilization of avelumab switch maintenance among patients with advanced urothelial carcinoma without progression following treatment with first-line platinum-based chemotherapy
err2025-09-01
err0
errOAAI
errMoon, Helen H.; Aragon-Ching, Jeanny B.; Thompson, Allison; Abraham, Anup; Vlahiotis, Anna; Ike, Chiemeka; Benjumea, Darrin; Shao, Anran; Sun, Haiyan; Kearney, Mairead; Gharibian, Norbek; Hanson, Sarah; Li, Benjamin; Kirker, Melissa; Grivas, Petros
errShare
errSave
The Role of Liquid Biopsy in the Management of Patients with Genitourinary Malignancies
err2025-08-18
err0
PREAI
errBenjamin L. Maughan; Lars Dyrskjøt; Petros Grivas; Antonio Alcaraz; Emmanuel S. Antonarakis; Mehmet A. Bilen; Trinity Bivalacqua; Matthew R. Cooperberg; Liang Cheng; Shilpa Gupta
errShare
errSave
HER2 and urothelial carcinoma: current understanding and future directions
err2025-08-15
err0
PREAI
errDaniele Raggi; Emanuele Crupi; Filippo Pederzoli; Alberto Martini; Alberto Briganti; Omar Alhalabi; Peter H. O’Donnell; Jeffrey Ross; Shilpa Gupta; Ashish M. Kamat; Bishoy M. Faltas; Peter C. Black; Phillip E. Spiess; Petros Grivas; Jianjun Gao; Andrea B. Apolo; Robert A. Huddart; Andrea Necchi; Matthew D. Galsky
errShare
errSave
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
err2025-08-05
err0
PREAI
errRuben Raychaudhuri; Ali Raza Khaki; Mary W. Redman; Kelsey K. Baker; Kevin Ng; Xueyan Chen; Jenny Mao; Brianna Woo; Aaron Lin; Andrii Hannochka; Nathan Conrad; Martha Kahugu; Patrick Panlasigui; Michael C. Haffner; Andrew C. Hsieh; Hung-Ming Lam; Funda Vakar-Lopez; Todd Yezefski; Michael T. Schweizer; Robert B. Montgomery; Evan Y. Yu; Atreya Dash; Sarah P. Psutka; Daniel W. Lin; George R. Schade; John L. Gore; Jonathan L. Wright; Petros Grivas
errShare
errSave
A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH)
err2025-07-01
err0
errOAAI
errChen, Wenwen; Majovski, Julia; Bhatia, Shailender; Chan, Anissa; Grivas, Petros; Lee, Sylvia; Shah, Sumit; Thompson, John A.; Tykodi, Scott S.; Veatch, Joshua R.; Schapira, Lidia; Hall, Evan T.
errShare
errSave
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease
err2025-06-03
err0
errOAAI
errJoaquim Bellmunt; Thomas Powles; Se Hoon Park; Eric Voog; Begona P. Valderrama; Howard Gurney; Anders Ullén; Yohann Loriot; Srikala S. Sridhar; Norihiko Tsuchiya; Cora N. Sternberg; Jeanny B. Aragon-Ching; Daniel P. Petrylak; Miguel A. Climent Duran; Karin Tyroller; Jason Hoffman; Natalia Jacob; Petros Grivas; Shilpa Gupta
errShare
errSave